Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation… Read more
Stratec SE (STSEY) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.018x
Based on the latest financial reports, Stratec SE (STSEY) has a cash flow conversion efficiency ratio of 0.018x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.34 Million) by net assets ($240.08 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Stratec SE - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Stratec SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Stratec SE Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Stratec SE ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Oncopeptides AB (publ)
PINK:ONPPF
|
12.237x |
|
KJTS
KLSE:0293
|
0.018x |
|
Birko Birlesik Koyunlulular Mensucat Ticaret ve Sanayi AS
IS:BRKO
|
0.031x |
|
Gevelot
PA:ALGEV
|
0.028x |
|
AMIA Co. Ltd.
TW:8438
|
0.028x |
|
Central Plains Bancshares, Inc. Common Stock
NASDAQ:CPBI
|
0.026x |
|
Prevas AB Series B
LSE:0H2J
|
0.117x |
|
Sanstar Ltd
NSE:SANSTAR
|
N/A |
Annual Cash Flow Conversion Efficiency for Stratec SE (2002–2024)
The table below shows the annual cash flow conversion efficiency of Stratec SE from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $242.53 Million | $48.71 Million | 0.201x | +141.25% |
| 2023-12-31 | $233.33 Million | $19.43 Million | 0.083x | +82.38% |
| 2022-12-31 | $225.18 Million | $10.28 Million | 0.046x | -85.20% |
| 2021-12-31 | $205.76 Million | $63.47 Million | 0.308x | +67.12% |
| 2020-12-31 | $172.54 Million | $31.85 Million | 0.185x | +38.04% |
| 2019-12-31 | $159.01 Million | $21.26 Million | 0.134x | +70.31% |
| 2018-12-31 | $152.20 Million | $11.95 Million | 0.079x | -58.67% |
| 2017-12-31 | $157.84 Million | $29.98 Million | 0.190x | +67.93% |
| 2016-12-31 | $143.72 Million | $16.26 Million | 0.113x | -43.40% |
| 2015-12-31 | $130.28 Million | $26.03 Million | 0.200x | -43.67% |
| 2014-12-31 | $112.05 Million | $39.75 Million | 0.355x | +44.63% |
| 2013-12-31 | $97.18 Million | $23.84 Million | 0.245x | +729.52% |
| 2012-12-31 | $91.98 Million | $2.72 Million | 0.030x | -77.01% |
| 2011-12-31 | $83.23 Million | $10.71 Million | 0.129x | +538.58% |
| 2010-12-31 | $71.88 Million | $1.45 Million | 0.020x | -89.02% |
| 2009-12-31 | $59.29 Million | $10.88 Million | 0.183x | +95.22% |
| 2008-12-31 | $49.90 Million | $4.69 Million | 0.094x | -52.28% |
| 2007-12-31 | $48.58 Million | $9.57 Million | 0.197x | -10.44% |
| 2006-12-31 | $40.13 Million | $8.83 Million | 0.220x | +430.06% |
| 2005-12-31 | $31.52 Million | $1.31 Million | 0.041x | -73.32% |
| 2004-12-31 | $15.47 Million | $2.41 Million | 0.156x | +384.79% |
| 2003-12-31 | $12.87 Million | $413.00K | 0.032x | -99.98% |
| 2002-12-31 | $11.17K | $1.73 Million | 155.162x | -- |